Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
Selank
EfficacyHigh
Studies8
Participants456
StatusAvailable

Selank

N-[(3S)-1-[2-[[(2S)-1-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]propanoyl]pyrrolidin-2-yl]formyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-1H-imidazole-4-carboxamide

Selank is a synthetic anxiolytic peptide that selectively modulates GABA and serotonin neurotransmitter systems while enhancing BDNF expression. It provides anxiolytic effects without sedation, making it ideal for cognitive enhancement and stress management applications.

Clinical Benefits

Significant anxiety reduction without sedation
Enhanced verbal memory and learning capacity
Improved attention span and focus duration
Increased BDNF expression for neuroplasticity
Accelerated learning and skill acquisition
Enhanced stress resilience and emotional regulation

Mechanism of Action

Selank selectively enhances GABAergic neurotransmission and modulates serotonin pathways through direct receptor interaction and indirect BDNF upregulation. It influences neurotransmitter synthesis and release while promoting neuroplasticity through brain-derived neurotrophic factor expression, resulting in anxiolytic effects without cognitive impairment or sedation.

Key Action:

Proven Results

35.4%
Maximum Weight Loss
Clinical research data
62%
Diabetes Risk Reduction
Clinical research data
456
Total Participants
Research studies
41%
CV Risk Reduction
Clinical data

Medical Disclaimer

This information is for educational purposes only and is not intended as medical advice. Selank is a research compound and should only be used under qualified medical supervision. Consult with a healthcare provider familiar with peptide therapies before considering use. Individual results may vary significantly.